[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Injectable Drug Delivery Formulation Market Study 2015-2025, by Segment (Conventional Drug Delivery Formulations, Novel Drug Delivery Formulations, Long-acting Formulations), by Market (Autoimmune Diseases, Hormonal Disorders, Oncology), by Company (Becton, Dickinson and Company (U.S.), Baxter International Inc. (U.S.), Gerresheimer AG (Germany))

November 2018 | 60 pages | ID: GA01523612CEN
99Strategy

US$ 1,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Snapshot

The global Injectable Drug Delivery Formulation market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Conventional Drug Delivery Formulations
  • Novel Drug Delivery Formulations
  • Long-acting Formulations
Demand Coverage (Market Size & Forecast, Consumer Distribution):
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Others
Company Coverage (Sales data, Main Products & Services etc.):
  • Becton, Dickinson and Company (U.S.)
  • Baxter International Inc. (U.S.)
  • Gerresheimer AG (Germany)
  • Pfizer, Inc. (U.S.)
  • Schott AG (Germany)
  • Sandoz (Germany)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Eli Lilly and Company (U.S.)
Major Region Market
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa
1 INDUSTRY OVERVIEW

1.1 InjecTable Drug Delivery Formulation Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 INJECTABLE DRUG DELIVERY FORMULATION MARKET BY TYPE

2.1 By Type
  2.1.1 Conventional Drug Delivery Formulations
  2.1.2 Novel Drug Delivery Formulations
  2.1.3 Long-acting Formulations
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Autoimmune Diseases
  3.1.2 Hormonal Disorders
  3.1.3 Oncology
  3.1.4 Orphan Diseases
  3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Becton, Dickinson and Company (U.S.) (Company Profile, Sales Data etc.)
5.2 Baxter International Inc. (U.S.) (Company Profile, Sales Data etc.)
5.3 Gerresheimer AG (Germany) (Company Profile, Sales Data etc.)
5.4 Pfizer, Inc. (U.S.) (Company Profile, Sales Data etc.)
5.5 Schott AG (Germany) (Company Profile, Sales Data etc.)
5.6 Sandoz (Germany) (Company Profile, Sales Data etc.)
5.7 Teva Pharmaceutical Industries Ltd. (Israel) (Company Profile, Sales Data etc.)
5.8 Eli Lilly and Company (U.S.) (Company Profile, Sales Data etc.)

6 CONCLUSION

LIST OF TABLES

Table GLOBAL INJECTable DRUG DELIVERY FORMULATION MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global InjecTable Drug Delivery Formulation Market 2015-2018, by Type, in Volume
Table Global InjecTable Drug Delivery Formulation Market Forecast 2019-2025, by Type, in USD Million
Table Global InjecTable Drug Delivery Formulation Market Forecast 2019-2025, by Type, in Volume
Table Becton, Dickinson and Company (U.S.) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Becton, Dickinson and Company (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter International Inc. (U.S.) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Baxter International Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gerresheimer AG (Germany) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Gerresheimer AG (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. (U.S.) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Pfizer, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Schott AG (Germany) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Schott AG (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz (Germany) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Sandoz (Germany) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. (Israel) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Teva Pharmaceutical Industries Ltd. (Israel) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company (U.S.) Overview List
Table InjecTable Drug Delivery Formulation Business Operation of Eli Lilly and Company (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Global InjecTable Drug Delivery Formulation Market Growth 2015-2018, by Type, in USD Million
Figure Global InjecTable Drug Delivery Formulation Market Growth 2015-2018, by Type, in Volume


More Publications